Reps. Brady, McDermott Trade For Ways And Means Health Panel Posts
This article was originally published in The Pink Sheet Daily
The top posts of the House Ways and Means Committee’s Health Subcommittee will be taken over by newcomers to the panel, with Kevin Brady, R-Texas, as chairman and Jim McDermott, D-Wash., as ranking member.
You may also be interested in...
Rep. Pete Stark, D-Calif., often a critic of the pharmaceutical industry, lost his re-election bid, leaving the top Democratic spot open on the Ways and Means Committee’s Health Subcommittee. Subcommittee Chairman Wally Herger already planned to retire. All members of the Senate HELP and Finance Committees up for re-election won their races.
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.